Cytosolic SYT/SS18 isoforms are actin-associated proteins that function in matrix-specific adhesion

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Kim, Jaehong ^a,b,c   Swee, Mei ^a   Parks, William C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYTOPLASM PROTEIN; FIBRONECTIN; LAMININ; SYNOVIAL SARCOMA TRANSLOCATED PROTEIN; UNCLASSIFIED DRUG; BIOPOLYMER; ISOPROTEIN; ONCOPROTEIN; REPRESSOR PROTEIN; SS18 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; FOCAL ADHESION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RNA INTERFERENCE; CELL ADHESION; CELL LINE; CYTOSOL; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOPRECIPITATION; METABOLISM;

ACTINS; BIOPOLYMERS; CELL ADHESION; CELL LINE; CYTOSOL; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS;

EID: 68149126863     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006455     Document Type: Article

References (42)

1. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, et al. (1994) Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 7: 502-508.
2. Thaete C, Brett D, Monaghan P, Whitehouse S, Rennie G, et al. (1999) Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus. Hum Mol Genet 8: 585-591.
3. Soulez M, Saurin AJ, Freemont PS, Knight JC (1999) SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex. Oncogene 18: 2739-2746.
4. dos Santos NR, de Bruijn DR, Kater-Baats E, Otte AP, van Kessel AG (2000) Delineation of the protein domains responsible for SYT, SSX, and SYT-SSX nuclear localization. Exp Cell Res 256: 192-202.
5. Brodin B, Haslam K, Yang K, Bartolazzi A, Xie Y, et al. (2001) Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression. Gene 268: 173-182.
6. Nagai M, Tanaka S, Tsuda M, Endo S, Kato H, et al. (2001) Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha. Proc Natl Acad Sci U S A 98: 3843-3848.
7. Xie Y, Skytting B, Nilsson G, Grimer RJ, Mangham CD, et al. (2002) The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery. Oncogene 21: 5791-5796.
8. Morimoto Y, Ouchida M, Ozaki T, Kawai A, Ito T, et al. (2003) Splicing isoform of SYT-SSX fusion protein accelerates transcriptional activity and cell proliferation. Cancer Lett 199: 35-43.
9. Pretto D, Barco R, Rivera J, Neel N, Gustavson MD, et al. (2006) The synovial sarcoma translocation protein SYT-SSX2 recruits beta-catenin to the nucleus and associates with it in an active complex. Oncogene 25: 3661-3669.
10. de Bruijn DR, Allander SV, van Dijk AH, Willemse MP, Thijssen J, et al. (2006) The Synovial Sarcoma-Associated SS18-SSX2 Fusion Protein Induces Epigenetic Gene (De)Regulation. Cancer Res 66: 9474-9482.
11. de Bruijn DR, dos Santos NR, Thijssen J, Balemans M, Debernardi S, et al. (2001) The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10. Oncogene 20: 3281-3289.
12. Kato H, Tjernberg A, Zhang W, Krutchinsky AN, An W, et al. (2002) SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones. J Biol Chem 277: 5498-5505.
13. Perani M, Ingram CJ, Cooper CS, Garrett MD, Goodwin GH (2003) Conserved SNH domain of the proto-oncoprotein SYT interacts with components of the human chromatin remodelling complexes, while the QPGY repeat domain forms homo-oligomers. Oncogene 22: 8156-8167.
14. Ishida M, Tanaka S, Ohki M, Ohta T (2004) Transcriptional co-activator activity of SYT is negatively regulated by BRM and Brg1. Genes Cells 9: 419-428.
15. Eid JE, Kung AL, Scully R, Livingston DM (2000) p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion. Cell 102: 839-848.
16. Perani M, Antonson P, Hamoudi R, Ingram CJ, Cooper CS, et al. (2005) The proto-oncoprotein SYT interacts with SYT-interacting protein/ co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins. J Biol Chem 280: 42863-42876.
17. Barco R, Garcia C, Eid J (2009) The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1. PLoS ONE 4: e5060.
18. de Bruijn DR, Baats E, Zechner U, de Leeuw B, Balemans M, et al. (1996) Isolation and characterization of the mouse homolog of SYT, a gene implicated in the development of human synovial sarcomas. Oncogene 13: 643-648.
19. de Bruijn DR, Kater-Baats E, Eleveld M, Merkx G, Geurts Van Kessel A (2001) Mapping and characterization of the mouse and human SS18 genes, two human SS18-like genes and a mouse Ss18 pseudogene. Cytogenet Cell Genet 92: 310-319.
20. Aizawa H, Hu SC, Bobb K, Balakrishnan K, Ince G, et al. (2004) Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. Science 303: 197-202.
21. de Bruijn DR, Peters WJ, Chuva de Sousa Lopes SM, van Dijk AH, Willemse MP, et al. (2006) Targeted disruption of the synovial sarcoma-associated SS18 gene causes early embryonic lethality and affects PPARBP expression. Hum Mol Genet 15: 2936-2944.
22. Kimura T, Sakai M, Tabu K, Wang L, Tsunematsu R, et al. (2009) Human synovial sarcoma proto-oncogene Syt is essential for early embryonic development through the regulation of cell migration. Lab Invest.
23. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, et al. (1997) The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 137: 1445-1457.
24. Spradling KD, McDaniel AE, Lohi J, Pilcher BK (2001) Epsin 3 is a novel extracellular matrix-induced transcript specific to wounded epithelia. J Biol Chem 276: 29257-29267.
25. Dumin JA, Dickeson SK, Stricker TP, Bhattacharyya-Pakrasi M, Roby JD, et al. (2001) Procollagenase-1 (matrix metalloproteinase-1) binds the integrin α2β1 upon release from keratinocytes migrating on type I collagen. J Biol Chem 276: 29368-29374.
26. Kukalev A, Nord Y, Palmberg C, Bergman T, Percipalle P (2005) Actin and hnRNP U cooperate for productive transcription by RNA polymerase II. Nat Struct Mol Biol 12: 238-244.
27. Kawano Y, Fukata Y, Oshiro N, Amano M, Nakamura T, et al. (1999) Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol 147: 1023-1038.
28. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, et al. (1999) Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285: 895-898.
29. Raftopoulou M, Hall A (2004) Cell migration: Rho GTPases lead the way. Dev Biol 265: 23-32.
30. Hotulainen P, Lappalainen P (2006) Stress fibers are generated by two distinct actin assembly mechanisms in motile cells. J Cell Biol 173: 383-394.
31. Lecuit T, Lenne PF (2007) Cell surface mechanics and the control of cell shape, tissue patterns and morphogenesis. Nat Rev Mol Cell Biol 8: 633-644.
32. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285: 1028-1032.
33. Zamir E, Geiger B (2001) Components of cell-matrix adhesions. J Cell Sci 114: 3577-3579.
34. Wiesner S, Legate KR, Fassler R (2005) Integrin-actin interactions. Cell Mol Life Sci 62: 1081-1099.
35. Nguyen BP, Ren XD, Schwartz MA, Carter WG (2001) Ligation of integrin alpha 3beta 1 by laminin 5 at the wound edge activates Rho-dependent adhesion of leading keratinocytes on collagen. J Biol Chem 276: 43860-43870.
36. Orr AW, Stockton R, Simmers MB, Sanders JM, Sarembock IJ, et al. (2007) Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis. J Cell Biol 176: 719-727.
37. Van de Walle GR, Schoolmeester A, Iserbyt BF, Cosemans JM, Heemskerk JW, et al. (2007) Activation of alphaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alpha2beta1 on platelets. Blood 109: 595-602.
38. Danen EH, Sonneveld P, Brakebusch C, Fassler R, Sonnenberg A (2002) The fibronectin-binding integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis. J Cell Biol 159: 1071-1086.
39. Miao H, Li S, Hu YL, Yuan S, Zhao Y, et al. (2002) Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling. J Cell Sci 115: 2199-2206.
40. Swee MH, Parks WC, Pierce RA (1995) Developmental regulation of elastin production. Expression of tropoelastin pre-mRNA persists after downregulation of steady-state mRNA levels. J Biol Chem 270: 14899-14906.
41. Swee M, Wilson CL, Wang Y, McGuire JK, Parks WC (2008) Matrix metalloproteinase-7 (matrilysin) controls neutrophil egress by generating chemokine gradients. J Leukoc Biol 83: 1404-1412.
42. Sudbeck BD, Pilcher BK, Welgus HG, Parks WC (1997) Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments. J Biol Chem 272: 22103-22110.